disaster
WHO applauds South Africa’s leadership in advancing HIV prevention through lenacapavir rollout
By World Health Organization at ReliefWeb
· June 15, 2026
· 1 min read
. Launched in Secunda, Mpumalanga province, the introduction of the twice-yearly injectable pre-exposure prophylaxis (PrEP) option demonstrates South Africa’s continued commitment to expanding access to effective, people-centred prevention options. Dr Tedros Adhanom Ghebreyesus, WHO Director-General
Key takeaway “South Africa’s rollout of lenacapavir demonstrates the country’s continued commitment to expanding access to innovative HIV prevention tools,” said Dr Tereza Kasaeva, Director of WHO’s Department for HIV, TB, Hepatitis and STIs.
Why this matters
The rollout of lenacapavir in South Africa marks a significant step in the country's efforts to combat HIV, building on its existing reputation as a global leader in the HIV response. By introducing this highly effective prevention tool into public health programmes, South Africa is poised to accelerate progress towards ending HIV and reducing health inequities. The country's ability to move quickly from policy to implementation is a testament to its strong political commitment, scientific excellence, and community partnerships. The World Health Organization's support for South Africa's efforts underscores the importance of collaboration between governments, communities, and partners in addressing the HIV epidemic. As South Africa works towards ending HIV by 2030, its experience with lenacapavir will be closely watched by other countries seeking to adopt innovative HIV prevention tools, and its success could have far-reaching implications for global health efforts.
About this story
Original reporting by ReliefWeb . Christgiving surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit ReliefWeb . Have a tip or correction? Contact our newsroom .
Category: disaster ·
Published: June 15, 2026 ·
Source: ReliefWeb ·
Reading time: 1 min
newsletter" aria-label="Newsletter signup" style="margin:24px 0;padding:20px 24px;background:linear-gradient(135deg,#1e3a5f 0%,#2d5a8c 100%);border-radius:10px;color:#fff">
Get more Christgiving stories like this
Free weekly briefing covering disaster and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? . Launched in Secunda, Mpumalanga province, the introduction of the twice-yearly injectable pre-exposure prophylaxis (PrEP) option demonstrates South Africa’s continued commitment to expanding access to effective, people-centred prevention options. Dr Tedros Adhanom Ghebreyesus, WHO Director-General
When was this published? This article was first published on June 15, 2026 by ReliefWeb and curated for Christgiving readers.
Who reported this story? This story was reported by World Health Organization at ReliefWeb. To learn more about how Christgiving selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more disaster coverage from Christgiving, or browse our daily briefing and topic hubs .